Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles.

Angelica Ortiz | Jun Gui | Farima Zahedi | Pengfei Yu | Christina Cho | Sabyasachi Bhattacharya | Christopher J Carbone | Qiujing Yu | Kanstantsin V Katlinski | Yuliya V Katlinskaya | Simran Handa | Victor Haas | Susan W Volk | Angela K Brice | Kim Wals | Nicholas J Matheson | Robin Antrobus | Sonja Ludwig | Theresa L Whiteside | Cindy Sander | Ahmad A Tarhini | John M Kirkwood | Paul J Lehner | Wei Guo | Hallgeir Rui | Andy J Minn | Constantinos Koumenis | J Alan Diehl | Serge Y Fuchs
Cancer cell | 2019

Tumor-derived extracellular vesicles (TEV) "educate" healthy cells to promote metastases. We found that melanoma TEV downregulated type I interferon (IFN) receptor and expression of IFN-inducible cholesterol 25-hydroxylase (CH25H). CH25H produces 25-hydroxycholesterol, which inhibited TEV uptake. Low CH25H levels in leukocytes from melanoma patients correlated with poor prognosis. Mice incapable of downregulating the IFN receptor and Ch25h were resistant to TEV uptake, TEV-induced pre-metastatic niche, and melanoma lung metastases; however, ablation of Ch25h reversed these phenotypes. An anti-hypertensive drug, reserpine, suppressed TEV uptake and disrupted TEV-induced formation of the pre-metastatic niche and melanoma lung metastases. These results suggest the importance of CH25H in defense against education of normal cells by TEV and argue for the use of reserpine in adjuvant melanoma therapy.

Pubmed ID: 30645975

Associated grants

  • Agency: NIH HHS, United States
    Id: T35 OD010919
  • Agency: NCI NIH HHS, United States
    Id: F32 CA206431
  • Agency: NCI NIH HHS, United States
    Id: P01 CA165997
  • Agency: Wellcome Trust, United Kingdom
    Id: 210688/Z/18/Z
  • Agency: Medical Research Council, United Kingdom
    Id: MR/P008801/1
  • Agency: NCI NIH HHS, United States
    Id: R01 CA188575
  • Agency: NCI NIH HHS, United States
    Id: T32 CA009140
  • Agency: NCI NIH HHS, United States
    Id: R01 CA092900
  • Agency: NCI NIH HHS, United States
    Id: R01 CA216936
  • Agency: Wellcome Trust, United Kingdom
  • Agency: Wellcome Trust, United Kingdom
    Id: 101835/Z/13/Z
  • Agency: NCI NIH HHS, United States
    Id: T32 CA115299

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


GraphPad Prism (tool)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions

FlowJo (tool)

RRID:SCR_008520

Software for single-cell flow cytometry analysis. Its functions include management, display, manipulation, analysis and publication of the data stream produced by flow and mass cytometers.

View all literature mentions

Microsoft Excel (tool)

RRID:SCR_016137

Software application with data analysis tools and spreadsheet templates to track and visualize data. It is used to manage and process data.

View all literature mentions

GAPDH (D16H11) XP Rabbit mAb (antibody)

RRID:AB_10622025

This monoclonal targets GAPDH

View all literature mentions

Anti-Ubiquitin Mouse mAb (FK2) (antibody)

RRID:AB_10681625

This monoclonal targets Ubiquitin Mouse mAb (FK2)

View all literature mentions

PE anti-mouse IFNAR-1 (antibody)

RRID:AB_1134011

This monoclonal targets IFNAR-1

View all literature mentions

Stat1 (9H2) Mouse mAb (antibody)

RRID:AB_2240087

This monoclonal targets Stat1 (9H2) Mouse mAb

View all literature mentions

p38alpha (N-20) (antibody)

RRID:AB_632140

This polyclonal targets MAPK14, MAPK11

View all literature mentions

Beta-Tubulin Antibody (antibody)

RRID:AB_2210545

This polyclonal targets Beta-Tubulin

View all literature mentions

FITC anti-mouse/human CD11b (antibody)

RRID:AB_312788

This monoclonal targets CD11b

View all literature mentions

APC anti-mouse CD45 (antibody)

RRID:AB_312977

This monoclonal targets CD45

View all literature mentions

beta-TrCP (D13F10) Rabbit mAb (antibody)

RRID:AB_10545763

This monoclonal targets beta-TrCP (D13F10) Rabbit mAb

View all literature mentions

IFNAR1 antibody [EP899Y] (antibody)

RRID:AB_775764

This monoclonal targets IFNAR1

View all literature mentions

Fibronectin antibody (antibody)

RRID:AB_447655

This polyclonal targets Fibronectin

View all literature mentions